IDEAS home Printed from https://ideas.repec.org/f/pgu273.html
   My authors  Follow this author

Samira Guennif

Personal Details

First Name:Samira
Middle Name:
Last Name:Guennif
Suffix:
RePEc Short-ID:pgu273

Affiliation

Centre d'Économie de l'Université Paris-Nord (CEPN)
Université Paris-13

Paris, France
http://cepn.univ-paris13.fr/
RePEc:edi:cep13fr (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Chapters Books

Working papers

  1. Guennif, Samir & Ramani, Shyama, 2010. "Catching up in pharmaceuticals: a comparative study of India and Brazil," MERIT Working Papers 2010-019, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  2. Samira Guennif, 2009. "Aids In India," Working Papers id:1974, eSocialSciences.
  3. Samira Guennif, 2007. "Enjeux de santé publique sous gouvernance globale de la propriété intellectuelle. De l'usage des flexibilités prévues par l'ADPIC au Sud," CEPN Working Papers halshs-00176508, HAL.
  4. Samira Guennif, 2007. "Protection du brevet et promotion de la santé publique selon les accords de libre échange états-uniens : surenchères autour des standards minimums de l'AADPIC au Sud," CEPN Working Papers halshs-00176509, HAL.
  5. Valérie Revest & Samira Guennif, 2005. "Social structure and reputation: the NASDAQ case study," Post-Print halshs-00163731, HAL.

Articles

  1. Samira Guennif, 2012. "L'économie politique du brevet au Sud : dimensions industrielle et sanitaire," Mondes en développement, De Boeck Université, vol. 0(4), pages 85-98.
  2. Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.
  3. Samira Guennif & Julien Chaisse, 2007. "L'économie politique du brevet au sud : variations Indiennes sur le brevet pharmaceutique," Revue internationale de droit économique, De Boeck Université, vol. 0(2), pages 185-210.
  4. Samira Guennif & Claude Mfuka, 2005. "L'accès aux traitements antisida en Afrique : une analyse de la stratégie de brevet des entreprises multinationales," Mondes en développement, De Boeck Université, vol. 131(3), pages 75-86.
  5. Samira Guennif, 2002. "From knowledge to individual action. Confidence, the hidden face of uncertainty. A rereading of the works of Knight and Keynes," Mind & Society: Cognitive Studies in Economics and Social Sciences, Springer;Fondazione Rosselli, vol. 3(2), pages 13-28, September.

Chapters

  1. Shyama V. Ramani & Samira Guennif, 2012. "Catching up in the Pharmaceutical Sector: Lessons from Case Studies of India and Brazil," Chapters, in: Franco Malerba & Richard R. Nelson (ed.), Economic Development as a Learning Process, chapter 5, Edward Elgar Publishing.
  2. Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & N. Lalitha, 2011. "Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 1, Edward Elgar Publishing.
  3. Samira Guennif, 2011. "Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 11, Edward Elgar Publishing.

Books

  1. Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), 2011. "Intellectual Property, Pharmaceuticals and Public Health," Books, Edward Elgar Publishing, number 13876.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Guennif, Samir & Ramani, Shyama, 2010. "Catching up in pharmaceuticals: a comparative study of India and Brazil," MERIT Working Papers 2010-019, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).

    Cited by:

    1. Varma, Sumati & Nayyar, Rishika, 2014. "OFDI between India and the LAC Region : A firm level motive analysis," MPRA Paper 56219, University Library of Munich, Germany.
    2. Daems, Rutger & Maes, Edith & Ramani, Shyama V., 2011. "Global Framework for Differential Pricing of Pharmaceuticals," MERIT Working Papers 2011-054, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    3. Varsha Bangalee & Fatima Suleman, 2018. "A Comparative Study on Medicine Pricing in Brazil, Russia, India, China and South Africa (BRICS)," Global Journal of Health Science, Canadian Center of Science and Education, vol. 10(10), pages 152-152, October.

  2. Samira Guennif, 2009. "Aids In India," Working Papers id:1974, eSocialSciences.

    Cited by:

    1. Renaud Egreteau, 2010. "Instability at the Gate: India’s Troubled Northeast and its External Connections," Working Papers id:2547, eSocialSciences.
    2. Deepa Menon Choudhary, 2009. "Assessing Policy Choices For Managing SO2 Emisions From Indian Power Sector," Working Papers id:1957, eSocialSciences.
    3. Sébastien Oliveau, 2007. "Periurbanisation in Tamil Nadu: A Quantitative Approach," Working Papers id:1228, eSocialSciences.
    4. Nicolas Gravel & Abhiroop Mukhopadhyay, 2007. "Is India Better off Today than 15 Years ago? A Robust Multidimensional Answer," IDEP Working Papers 0704, Institut d'economie publique (IDEP), Marseille, France, revised 18 May 2007.
    5. Veronique Dupont, 2007. "Peri-Urban Dynamics: Case studies in Chennai, Hyderabad and Mumbai," Working Papers id:974, eSocialSciences.
    6. Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.
    7. Samira Guennif, 2007. "Enjeux de santé publique sous gouvernance globale de la propriété intellectuelle. De l'usage des flexibilités prévues par l'ADPIC au Sud," Working Papers halshs-00176508, HAL.
    8. Laurence Henry, 2007. "Trade and Economic Arrangements Between India and South Asia in the Context of Regional Construction and Globalisation," Working Papers id:1055, eSocialSciences.

  3. Valérie Revest & Samira Guennif, 2005. "Social structure and reputation: the NASDAQ case study," Post-Print halshs-00163731, HAL.

    Cited by:

    1. Riccardo Boero & Giangiacomo Bravo & Marco Castellani & Francesco Laganà & Flaminio Squazzoni, 2009. "Pillars of Trust: An Experimental Study on Reputation and Its Effects," Sociological Research Online, , vol. 14(5), pages 49-67, November.

Articles

  1. Samira Guennif, 2012. "L'économie politique du brevet au Sud : dimensions industrielle et sanitaire," Mondes en développement, De Boeck Université, vol. 0(4), pages 85-98.

    Cited by:

    1. Abecassis, Philippe & Coutinet, Nathalie, 2015. "Médicaments génériques : pivot de la reconstruction de l’industrie pharmaceutique," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.

  2. Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.

    Cited by:

    1. Fumio Teramae & Tomohiro Makino & Yeongjoo Lim & Shintaro Sengoku & Kota Kodama, 2020. "Impact of Research and Development Strategy on Sustainable Growth in Multinational Pharmaceutical Companies," Sustainability, MDPI, vol. 12(13), pages 1-15, July.
    2. Si Zhang & Shirong Gu & Yuxuan Tang, . "How does policy create an opportunity window for China’s digital economy?," UNCTAD Transnational Corporations Journal, United Nations Conference on Trade and Development.
    3. Yexin Liu & Weiwei Wu & Yanggi Kim, 2023. "How do latecomer firms achieve catch-up through technology management: a comparative analysis," Palgrave Communications, Palgrave Macmillan, vol. 10(1), pages 1-12, December.
    4. Mukherjee, Debmalya & Kumar, Satish & Mukherjee, Deepraj & Goyal, Kirti, 2022. "Mapping five decades of international business and management research on India: A bibliometric analysis and future directions," Journal of Business Research, Elsevier, vol. 145(C), pages 864-891.
    5. Akçomak, Ibrahim Semih & Bürken, Serkan, 2019. "The middle-technology trap: The case of the automotive industry in Turkey," MERIT Working Papers 2019-006, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    6. Ramani, Shyama V. & Urias, Eduardo, 2018. "When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil," Research Policy, Elsevier, vol. 47(8), pages 1538-1552.
    7. Loitongbam, Bishwanjit Singh, 2016. "Impact of TRIPS and RTAs on the Indian Pharmaceutical Product Exports," MPRA Paper 75764, University Library of Munich, Germany, revised 27 May 2016.
    8. Loitongbam, Bishwanjit Singh, 2016. "Globalization and Innovation in the Indian Pharmaceutical Industry," MPRA Paper 75925, University Library of Munich, Germany, revised 27 May 2016.
    9. Keun Lee & Tae Young Park & Rishikesha T. Krishnan, 2014. "Catching-up or Leapfrogging in the Indian IT Service Sector: Windows of Opportunity, Path-creating, and Moving up the Value Chain," Development Policy Review, Overseas Development Institute, vol. 32(4), pages 495-518, July.
    10. Basant, Rakesh & Srinivasan, Shuchi, 2015. "Intellectual Property Protection in India and Implications for Health Innovation: Emerging Perspectives," IIMA Working Papers WP2015-04-01, Indian Institute of Management Ahmedabad, Research and Publication Department.
    11. Paola Perez-Aleman & Tommaso Ferretti, 2023. "Creating innovation capabilities for improving global health: Inventing technology for neglected tropical diseases in Brazil," Journal of International Business Policy, Palgrave Macmillan, vol. 6(1), pages 84-114, March.
    12. Lu Xu & Jie Xiong & Jie Yan & Richard Soparnot & Zhe Yuan, 2023. "Technological Uncertainty and Catch-Up Patterns: Insights of Four Chinese Manufacturing Sectors," Grenoble Ecole de Management (Post-Print) hal-04011634, HAL.
    13. Kwak, Kiho & Kim, Namil, 2022. "Industrial Leadership Changes without Technological Discontinuity: Modularization, Institution-Led Market Discontinuity, and Market Development Strategy," Technological Forecasting and Social Change, Elsevier, vol. 180(C).
    14. Na Zhang & Chao Sun & Min Xu & Xuemei Wang & Jia Deng, 2023. "Catching Up of Latecomer Economies in ICT for Sustainable Development: An Analysis Based on Technology Life Cycle Using Patent Data," Sustainability, MDPI, vol. 15(11), pages 1-29, June.
    15. Giachetti, Claudio & Mensah, Deborah Tiniwah, 2023. "Catching-up during technological windows of opportunity: An industry product categories perspective," Research Policy, Elsevier, vol. 52(2).
    16. Anil Nair & Orhun Guldiken & Stav Fainshmidt & Amir Pezeshkan, 2015. "Innovation in India: A review of past research and future directions," Asia Pacific Journal of Management, Springer, vol. 32(4), pages 925-958, December.
    17. Mike W Peng & David Ahlstrom & Shawn M Carraher & Weilei (Stone) Shi, 2017. "An institution-based view of global IPR history," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 48(7), pages 893-907, September.
    18. Lei Guo & Marina Yue Zhang & Mark Dodgson & David Gann & Hong Cai, 2019. "Seizing windows of opportunity by using technology-building and market-seeking strategies in tandem: Huawei’s sustained catch-up in the global market," Asia Pacific Journal of Management, Springer, vol. 36(3), pages 849-879, September.
    19. Lu Xu & Jie Xiong & Jie Yan & Richard Soparnot & Zhe Yuan, 2023. "Technological Uncertainty and Catch-Up Patterns: Insights of Four Chinese Manufacturing Sectors," Post-Print hal-04011634, HAL.
    20. Lee, Keun & Malerba, Franco, 2017. "Catch-up cycles and changes in industrial leadership:Windows of opportunity and responses of firms and countries in the evolution of sectoral systems," Research Policy, Elsevier, vol. 46(2), pages 338-351.
    21. Fischer, Bruno Brandão & Schaeffer, Paola Rücker & Vonortas, Nicholas S., 2019. "Evolution of university-industry collaboration in Brazil from a technology upgrading perspective," Technological Forecasting and Social Change, Elsevier, vol. 145(C), pages 330-340.
    22. Landini, Fabio & Lee, Keun & Malerba, Franco, 2017. "A history-friendly model of the successive changes in industrial leadership and the catch-up by latecomers," Research Policy, Elsevier, vol. 46(2), pages 431-446.
    23. Lee, Keun & Ki, Jee-hoon, 2017. "Rise of latecomers and catch-up cycles in the world steel industry," Research Policy, Elsevier, vol. 46(2), pages 365-375.
    24. Schüren Verena, 2013. "What a difference a state makes: pharmaceutical innovation after the TRIPs agreement," Business and Politics, De Gruyter, vol. 15(2), pages 217-243, August.
    25. Giachetti, Claudio & Marchi, Gianluca, 2017. "Successive changes in leadership in the worldwide mobile phone industry: The role of windows of opportunity and firms’ competitive action," Research Policy, Elsevier, vol. 46(2), pages 352-364.
    26. Majidpour, Mehdi & Saber, Ali & Elahi, Shaban & Shayan, Ali & Sahebkar Khorasani, Seyed Mohammad, 2021. "Technological catch-up in the biopharmaceutical sector: Evidence from Iran," Technology in Society, Elsevier, vol. 67(C).
    27. Chung, Chao-chen, 2013. "Government, policy-making and the development of innovation system: The cases of Taiwanese pharmaceutical biotechnology policies (2000–2008)," Research Policy, Elsevier, vol. 42(5), pages 1053-1071.
    28. Khayyat, Nabaz T. & Lee, Jeong-Dong, 2015. "A measure of technological capabilities for developing countries," Technological Forecasting and Social Change, Elsevier, vol. 92(C), pages 210-223.
    29. Angelo Kenneth S. Romasanta & Peter Sijde & Jacqueline Muijlwijk-Koezen, 2020. "Innovation in pharmaceutical R&D: mapping the research landscape," Scientometrics, Springer;Akadémiai Kiadó, vol. 125(3), pages 1801-1832, December.
    30. Han Huang & Jie Xiong & Junfang Zhang, 2021. "Windows of Opportunity in the CoPS’s Catch-Up Process: A Case Study of China’s High-Speed Train Industry," Sustainability, MDPI, vol. 13(4), pages 1-16, February.
    31. Guennif, Samira, 2015. "La licence obligatoire : outil emblématique de la protection de la santé publique au Sud," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
    32. Ewa Chomać-Pierzecka, 2023. "Pharmaceutical Companies in the Light of the Idea of Sustainable Development—An Analysis of Selected Aspects of Sustainable Management," Sustainability, MDPI, vol. 15(11), pages 1-23, May.
    33. Xiong, Jie & Zhao, Shuyan & Meng, Yan & Xu, Lu & Kim, Seong-Young, 2022. "How latecomers catch up to build an energy-saving industry: The case of the Chinese electric vehicle industry 1995–2018," Energy Policy, Elsevier, vol. 161(C).
    34. Eduardo Urias & Shyama V. Ramani, 2020. "Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence," Journal of International Business Policy, Palgrave Macmillan, vol. 3(4), pages 367-384, December.
    35. Ray, Sangeeta & Ray, Pradeep Kanta, 2021. "Innovation strategy of latecomer firms under tight appropriability regimes: The Indian pharmaceuticals industry," Journal of International Management, Elsevier, vol. 27(1).

  3. Samira Guennif & Julien Chaisse, 2007. "L'économie politique du brevet au sud : variations Indiennes sur le brevet pharmaceutique," Revue internationale de droit économique, De Boeck Université, vol. 0(2), pages 185-210.

    Cited by:

    1. Samira Guennif, 2007. "Enjeux de santé publique sous gouvernance globale de la propriété intellectuelle. De l'usage des flexibilités prévues par l'ADPIC au Sud," CEPN Working Papers halshs-00176508, HAL.
    2. Samira Guennif, 2007. "Global harmonisation of intellectual property rights and local impact. Patent and access to medicines in developing countries under TRIPS and TRIPS plus provisions [Harmonisation globale des systèm," Post-Print hal-01345869, HAL.
    3. Samira Guennif, 2007. "Enjeux de santé publique sous gouvernance globale de la propriété intellectuelle. De l'usage des flexibilités prévues par l'ADPIC au Sud," Working Papers halshs-00176508, HAL.

Chapters

  1. Shyama V. Ramani & Samira Guennif, 2012. "Catching up in the Pharmaceutical Sector: Lessons from Case Studies of India and Brazil," Chapters, in: Franco Malerba & Richard R. Nelson (ed.), Economic Development as a Learning Process, chapter 5, Edward Elgar Publishing.

    Cited by:

    1. Jun-Youn Kim & Tae-Young Park & Keun Lee, 2013. "Catch-Up by Indigenous Firms in the Software Industry and the Role of the Government in China: A Sectoral System of Innovation (SSI) Perspective," Eurasian Business Review, Springer;Eurasia Business and Economics Society, vol. 3(1), pages 100-120, June.

  2. Samira Guennif, 2011. "Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 11, Edward Elgar Publishing.

    Cited by:

    1. Samira Guennif, 2017. "Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries," Applied Health Economics and Health Policy, Springer, vol. 15(5), pages 557-565, October.
    2. Guennif, Samira, 2015. "La licence obligatoire : outil emblématique de la protection de la santé publique au Sud," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.

Books

  1. Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), 2011. "Intellectual Property, Pharmaceuticals and Public Health," Books, Edward Elgar Publishing, number 13876.

    Cited by:

    1. G. Alenka Guzmán Chávez. & Hortensia Gómez Víquez. & Francisco López Herrera., 2018. "Patentes y crecimiento económico, el caso de México durante el TLCAN," Economía: teoría y práctica, Universidad Autónoma Metropolitana, México, vol. 0(2), pages 177-204, Agosto.
    2. Samira Guennif, 2017. "Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries," Applied Health Economics and Health Policy, Springer, vol. 15(5), pages 557-565, October.
    3. Olsen Tricia D. & Sinha Aseema, 2013. "Linkage politics and the persistence of national policy autonomy in emerging powers: patents, profits, and patients in the context of TRIPS compliance," Business and Politics, De Gruyter, vol. 15(3), pages 323-356, October.
    4. Guennif, Samira, 2015. "La licence obligatoire : outil emblématique de la protection de la santé publique au Sud," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 2 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-CWA: Central and Western Asia (1) 2009-05-30
  2. NEP-SOG: Sociology of Economics (1) 2007-08-08

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Samira Guennif should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.